Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Current Deferred Revenue (2011 - 2026)

Updated

Nuo Therapeutics (AURX) reported Current Deferred Revenue of $311,765 for Q2 2026, up 3.9% from $300,000 a year earlier.

Analysis

Nuo Therapeutics (AURX) Current Deferred Revenue (2011 - 2026) Analysis & Trends

At the end of FY2025, Nuo Therapeutics posted Current Deferred Revenue of $300,000.

  • The Q2 2026 figure ranks as the highest quarterly Current Deferred Revenue since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Nuo Therapeutics 60.54 Mn 58.71 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 311,765.00
Dec 31, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 200,000.00
Dec 31, 2018 1,634.00
Dec 31, 2017 20,896.00
Mar 31, 2016 402,357.00
Dec 31, 2015 523,900.00
Sep 30, 2015 584,671.00
Jun 30, 2015 402,377.00
Mar 31, 2015 402,377.00
Dec 31, 2014 402,377.00
Sep 30, 2014 402,377.00
Jun 30, 2014 402,377.00
Mar 31, 2014 470,009.00
Dec 31, 2013 740,990.00
Sep 30, 2013 2.50 Mn
Jun 30, 2013 8,006.00
Mar 31, 2012 1.82 Mn
API Access

Nuo Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AURX&period=max&api_key=YOUR_API_KEY